ARCHIVING A COMPLEX DATASET: IST-3 A CASE STUDY by Jonathan Drever.

Slides:



Advertisements
Similar presentations
UPDATE ON THROMBOLYTIC THERAPY Markku Kaste Department of Neurology Helsinki University Central Hospital (HUCH) University of Helsinki Markku Kaste Department.
Advertisements

Breaking news from IST-3 Peter Sandercock University of Edinburgh on behalf of the IST-3 collaborative group ESC London 29 th May 2013.
TPA in Stroke: What's All the Fuss?. FERNE Brain Illness and Injury Course.
Better or bigger: How should we organise emergency care Jon Nicholl School of Health and Related Research University of Sheffield England.
Thrombolysis for stroke in older people.
EM TREATMENT OF ACUTE STROKE Progress, Problems, Politics William G. Barsan, M.D. University of Michigan.
ATLAS Steering Committee: 24 September 2005 Steering Committee meeting, 24 th September 2005 University of Oxford Examination Schools.
Information Technology IBM DB2 Content Manager “Lunch N Learn” 03/14/2007.
The third international stroke trial (IST-3) of thrombolysis main results III. Effect of iv thrombolysis with iv rt-PA on death or dependency in the 3035.
Life Sciences Accelerated R&D Services The Science of Getting Products to Patients Faster Study Data Standardization Plan Use Case Experience Dave Izard.
T-PA in Treatment of Acute Stroke: What We Know From NINDS 2004 vs 2000 Sidney Starkman, MD Departments of Emergency Medicine and Neurology, UCLA UCLA.
SYDNEY MEDICAL SCHOOL What do the IST-3 results mean for the elderly patient with acute stroke? Westmead Hospital Clinical School | George Institute for.
Complex Care Management In Practice Dunblane Tuesday 6 th November 2007.
Are the results valid? Was the validity of the included studies appraised?
The third international stroke trial (IST-3) of rt-PA. Main Results II: IST3 in context of updated meta-analysis of the randomised trials. JM Wardlaw,
SimplifyMD System Overview. Login Enter your User Name and password Login and work under your User Name Electronic systems record : Charts viewed Messages.
IST-3 – an imaging substudy Dr Ingrid Kane Clinical research fellow.
Stroke,Past,Present, Future. Impact of stroke 1,2 Stroke has a major impact on people’s lives Stroke is the: –single most devastating effect of hypertension.
The third international stroke trial (IST-3) main results: primary and secondary outcomes among 3035 patients The IST3 collaborative group hospitals.
Background  Clinical pharmacists frequently base treatment recommendations on the primary literature.  Recalling specific details about clinical trials.
BBS CONTACT CAPABILITY REVIEW: WEB WIREFRAMES PROPOSAL VERSION.
The need for trials of i.v. thrombolysis in acute ischaemic stroke 10 th January 2008.
TELEMEDICINE AND RESEARCH. THE TELEICTUS PROJECT IN THE HOSPITAL St JOHN OF GOD´S OF ALJARAFE. Antonio Fernández Moyano MD. PhD. Internal Medicine Service.
What is touchPRO EXPRESS? touchPRO EXPRESS is a way for Schools who meet certain criteria to be able to get a mobile app at a low cost and have their app.
What’s on the horizon? Peter Sandercock ESC Lisbon 23rd May 2012.
Thrombolysis in acute ischaemic stroke – Updated Cochrane Thrombolysis metaanalysis JM Wardlaw, V Murray, PAG Sandercock University of Edinburgh and Karolinska.
Tissue Plasminogen Activator for Acute Ischemic Stroke National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
Evidence in the ED Byron Drumheller, MD Penn Emergency Medicine.
28th April 2008 What scans to perform for patients entered in IST3 and how to send them to the trial office Eleni Sakka Joanna Wardlaw Peter Sandercock.
Update on IST-3 and other trials. Or, ‘how the ECASS-3 results have helped re-launch IST-3!’ Professor Peter Sandercock, Co-chief investigator IST-3 collaborator’s.
S afe I mplementation of T hrombolysis in S troke Slide presentation adapted from
The third international stroke trial (IST-3) effect of thrombolysis on outcomes at 18 months in 2348 patients in long-term follow- up cohort The IST3 collaborative.
Formic software training for the SCOOP study Mikey Desai, Training Consultant, Formic Ltd Liz Lenaghan, SCOOP Study Manager, UEA.
1 CSI Database Tool Update. 2 Content CSI Online Tutorial Reporting and Data Subcommittee Update: Reporting requirements Data integrity Potential enhancements:
RMH Comprehensive Stroke Centre Thrombolysis and Stroke Units : The Evidence Professor Stephen Davis Royal Melbourne Hospital Comprehensive Stroke Centre.
Acute Ischemic Stroke Treatments Patrick J. Ward, PA-S.
Mr X, 79 years old Admitted on 5/5/00 to WGH stroke unit Dense (0/5) right arm and leg paresis Aphasic CT scan excluded a bleed Given trial treatment (IST-3)
] COREY PEARSON [ ASUG INSTALLATION MEMBER MEMBER SINCE: 2008 CHAVONE JACOBS [ ASUG INSTALLATION MEMBER MEMBER SINCE: 2003 ALLAN FISHER [ ASUG INSTALLATION.
Thrombolysis for patients > 80 – a different view Peter Sandercock On behalf of the IST3 collaborative Group UKSF Glasgow 1 st December 2009.
Third International Stroke Trial (IST-3): response to ECASS-3 results Professor Peter Sandercock, University of Edinburgh Collaborators Meeting Vienna.
Consent in acute stroke trials: a view from IST3 Peter Sandercock University of Edinburgh SRN Training Day Newcastle 25 th June 2008.
Can patients be too mild, too severe or too old for thrombolysis? Professor Peter Sandercock University of Edinburgh ESC Hamburg 27 th May 2011 Disclosures.
IST-3: What are the implications for rt-PA therapy? Peter Sandercock University of Edinburgh on behalf of the IST-3 collaborative group ESC Lisbon 23rd.
Thrombolysis for acute ischaemic stroke Clinical
1 Pulminiq™ Cyclosporine Inhalation Solution Pulmonary Drug Advisory Committee Meeting June 6, 2005 Statistical Evaluation Statistical Evaluation Jyoti.
Thrombolysis: The Evidence Barry Moynihan Stroke Physician, St. George’s Hospital SITS/BASP Thrombolysis Nursing Training Day March 26 th 2012.
IST-3, SITS MOST ECASS-3 & DEFUSE Professor Peter Sandercock University of Edinburgh, UK ESC May 30 th 2007 Glasgow Competing interests:
Analysis. This involves investigating what is required from the new system and what facilities are available. It would probably include:
Supporting the NHS to deliver better, safer, quality care NHS Connecting for Health.
PROV NETWORK MEETING Linda Tolson, Corporate Records Manager 6 May, 2016.
Data quality & VALIDATION
Royal College of Physicians of Edinburgh Scottish Stroke Collaboration Meeting 22nd September 2010 Queen Mother Conference Centre.
Trials Adrian Boyle.
REFLECT: Recovery Following Intensive Care Treatment
MAINTAINING THE INVESTIGATOR’S SITE FILE
Royal College of Physicians of Edinburgh Scottish Stroke Collaboration Meeting 22nd September 2010 Queen Mother Conference Centre.
Baseline characteristics of the 3035 patients recruited in IST3
AIM HIGH Niacin plus Statin to prevent vascular events
Volume 384, Issue 9958, Pages (November 2014)
Volume 384, Issue 9958, Pages (November 2014)
Pearls Presentation Use of N-Acetylcysteine For prophylaxis of Radiocontrast Nephrotoxicity.
Volume 14, Issue 5, Pages (May 2015)
Keeping all your medical forms in one location
MAINTAINING THE INVESTIGATOR’S STUDY FILE
Volume 379, Issue 9834, Pages (June 2012)
Volume 14, Issue 5, Pages (May 2015)
Volume 375, Issue 9719, Pages (March 2010)
Volume 13, Issue 12, Pages (December 2014)
Volume 12, Issue 8, Pages (August 2013)
ECASS-II: intravenous alteplase in acute ischaemic stroke
Presentation transcript:

ARCHIVING A COMPLEX DATASET: IST-3 A CASE STUDY by Jonathan Drever

Third International Stroke Trial “The benefits and harms of intravenous thrombolysis with alteplase within 6 h of acute ischaemic stroke” 3035 Patients from 156 Hospitals in 12 Countries Baseline, 7 Day, 6m and 18m CRFs Pre and Post Randomisation Brain Imaging

IST-3 Results Favourable shift; adjusted common odds ratio 1·27 (95% CI 1·10- 1·47), p=0·001 or, the odds of surviving with less disability were 27% greater for patients treated with rt-PA

Challenges Core Data (CRFs) Scan Housekeeping DICOM Imaging Imaging Reviews Sub- Study

Data Eccentricities Legacy Data Blinded / Startup Phase of the trial Paper Scan reads Empty fields Pre and Post Calculated Values Duplicated Data Administration Data Form sent and received dates Centre activation dates Missing Data Form version change NULL, 9 and Unknown

Documentation 1. Plain English 1. Bullet Points 1. The Devils in the Detail

Annotated Form

Form Versions

Creating a Basic Dataset Benefits Simpler to understand and analyse Cleanest most complete data Snapshots Concentrate your efforts IST-3 Dataset Up to 6m Very limited scan data Used for main trial paper and further meta-analysis More use in future…?

Archiving (Paper) Long Term store (15yrs) Resources (where?) Huge amounts of paper (114 boxes) Only 1 box was the electronic files

Archiving (electronic) Bringing it all together Investigation Cleaning Documentation Basic Dataset Archiving Catalogue All the electronic repositories Rough view of contents Points to more detail

Archiving (Technicalities)

Next Steps 2 nd Round of Archiving Further Analysis Data Sharing Updated ‘Basic Dataset’ What documentation is needed? Where will it do? (Edinburgh DataShare) Who will get access?

Take Home Messages Planning early Simple documentation Value of a basic dataset Factor in your resources Be pragmatic Its not just for Archiving